Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: Results with low molecular weight heparin

International Journal of Cardiology

Volumn 98, Issue 1, 2005, Pages 49-55

  Akdeniz, Bahri ^a   Türker, Sonay ^a   Öztürk, Volkan ^a   Badak, Özer ^a   Okan, Taha ^a   Aslan, Özgür ^a   Kozan, Ömer ^a   Kirimli, Önder ^a   Aytekin, Deniz ^a   Bariş, Nezihi ^a   Güneri, Sema ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Low molecular weight heparin; Persistent atrial fibrillation; TEE guided cardioversion

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTERY EMBOLISM; ARTICLE; BLEEDING; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS RHYTHM; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMBINED MODALITY THERAPY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART CONDUCTION SYSTEM; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; THROMBOSIS; TREATMENT OUTCOME;

EID: 19944434279     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.10.019     Document Type: Article

References (26)

1. Feinberg W.M., Blackshear J.L., Laupais A., et al. Prevalence age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch. Intern. Med. 155:1995;469-473
2. Prystowsky E.N., Benson D.W., Fuster W. Management of patients with atrial fibrillation: a statement of healthcare professionals: from the subcommittee on electrocardiography and echocardiography and electrophysiology. American Heart Association. Circulation. 33:1996;1262-1277
3. Ostrander L.D., Brandt R.L., Kjelsberg M.O. Electrocardiographic findings among the adult populations of a natural community. Circulation. 31:1965;888-898
4. Stein B., Halperin J.L., Fuster V. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? Cardiovasc. Clin. 21:1990;231-247
5. Lown B. Electrical cardioversion of cardiac arrythmias. Br. Heart J. 29:1967;469-489
6. Grimm R.A., Stewart W.J., Black J.W., et al. Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation? J. Am. Coll. Cardiol. 23:1994;533-541
7. Laupacis A., Albers G., Dalen J., et al. Antithrombotic therapy in atrial fibrillation. Chest. 114:1998;579S-589S. [Suppl.]
8. Aschenberg W., Schlutter M., Kremer P., et al. Transesophageal two dimensional echocardiography for the detection of left atrial appendage thrombus. J. Am. Coll. Cardiol. 7:1986;163-166
9. Fatkin D., Scalia G., Jakobs N., et al. Accuracy of biplane transesophageal echocardiography in detection left atrial thrombus. Am. J. Cardiol. 77:1996;321-323
10. Sewaer J.B., Khanderia B.K., Freeman W.K., et al. Multiplane transesophageal echocardiography image orientation, examination technique, anatomic correlation and clinical applications. Mayo. Clin. Proc. 68:1993;523-551
11. Manning W.J., Weintraub R.M., Waksmonski C.A., et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. Ann. Intern. Med. 123:1995;817-822
12. Klein A.L., Murray R.D., Grimm R.A., et al. Role of transesophageal echocardiography guided cardioversion of patients with atrial fibrillation. Review article. J. Am. Coll. Cardiol. 37:2001;691-704
13. Kamp O., Verhost P.J., Visser A.C., et al. Transesophageal echocardiography for early cardioversion of atrial fibrillation. Am. J. Cardiol. 86:2000;46G-50G. [Suppl.]
14. Hirsh J., Fuster V. Low molecular weight heparin. Blood. 79:1992;1
15. Simmoneau G., Charbonnier D., Decousus, et al. Subcutaneous low molecular weight heparin compared with continuos intravenous unfractioned heparin in the prevention of in the treatment of proximal deep venous thrombosis. Arch. Intern. Med. 151:1993;1541
16. Hirsh J., Warketing T.E., Raschke R., et al. Heparin and low molecular weight heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring efficacy and safety. Chest. 114:1998;489S-510S
17. Daniel W.G., Nellsessen U., Schroder E., et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J. Am. Coll. Cardiol. 11:1998;1204-1211
18. Klein A.L., Grimm R.A., Murray R.D., et al. Use Of Transesophageal Echocardiography to Guide Cardioversion in patients with atrial fibrillation. (ACUTE) N. N. Engl. J. Med. 344:2001;1411-1420
19. Seidl K., Rameken M., Drögemüller A., et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: Value of transesophageal echocardiography to guide direct current cardioversion. J. Am. Coll. Cardiol. 39:2002;1436-1442
20. The Atrial Fibrillation Follow-up Investigation of Rhythm management (AFFIRM) Investistiagtors A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 347:2002;1825-1833
21. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med. 347:2002;1834-1840
22. Orsinelli D.A., Pearson A.C. Usefulness of transesophageal echocardiography to screen for left atrial thrombus before electrical cardioversion for atrial fibrillation. Am. J. Cardiol. 72:1993;1337-1339
23. Corrado G., Tadeo G., Beereta S., et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest. 115:1999;140-143
24. Stoddard M.F., Dawkins P.R., Prince C.R., et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J. Am. Coll. Cardiol. 25:1995;452-459
25. Collins L.J., Silverman D.I., Douglas P.S., et al. Cardioversion of nonrheumatic atrial fibrillation: reduced thromembolic complications with four weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation. 92:1995;160-163
26. Jaber W.A., Prrior D.L., Thamilarasan M., et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study. Am. Heart J. 140:2000;150-156